Literature DB >> 12940165

Myelopeptide-2 induces the resistance of T-lymphocytes to tumor suppression.

S V Khabarov1, G K Gerasimova, A A Mikhailova, R V Petrov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12940165     DOI： 10.1023/a:1024486323550

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN： 0012-4966


× No keyword cloud information.
  5 in total

1.  [Reason for the damping effect of tumor cells on human T-lymphocytes].

Authors:  L A Strelkov; A A Mikhaĭlova; A M Sapozhnikov; R V Petrov
Journal:  Dokl Akad Nauk       Date:  1996-03

2.  The bone marrow peptide (myelopeptide-2) abolishes induced by human leukemia HL-60 cell suppression of T lymphocytes.

Authors:  L A Strelkov; A A Mikhailova; A M Sapozhnikov; L A Fonina; R V Petrov
Journal:  Immunol Lett       Date:  1996-05       Impact factor: 3.685

3.  An [35S]methionine cytotoxicity assay requiring small numbers of effector and target cells.

Authors:  K E Stedman; P A Campbell
Journal:  J Immunol Methods       Date:  1989-05-12       Impact factor: 2.303

4.  [A myelopeptide, ameliorating the toxic effect of tumor cells on the functional activity of T-lymphocytes].

Authors:  L A Strelkov; A A Mikhaĭlova; L A Fonina; R V Petrov
Journal:  Dokl Akad Nauk       Date:  1994-09

5.  [A novel immunoregulating hexapeptide with antineoplastic effect].

Authors:  E M Treshchalina; L A Sedakova; N K Vlasenkova; O S Zhukova; G A Firsova; L M Mikhaĭlova; E Iu Kolesnikova; N I Zimakova; S V Khabarov; G K Gerasimova
Journal:  Vopr Onkol       Date:  2001
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.